Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Intellia Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 296
- +5 vs. Q4 2024
- Shares held
- 101.3M
- +2.26M (+2.3%) vs. Q4 2024
- Total value
- $720.3M
- −$435.4M (−37.7%) vs. Q4 2024
- New holders
- 51
- 94 more added
- Sold out
- 46
- 96 more reduced
4 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −279,693−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −182,434−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −108,351−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −98,700−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −95,339−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −71,100−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −69,354−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −67,282−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −67,130−100.0% | Sold out |
| Evolutionary Tree Capital Management, LLC | 0 | $0 | 0.00% | −47,406−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −42,869−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −35,586−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −32,425−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −31,015−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −30,010−100.0% | Sold out |
| RMB Capital Management, LLC | 0 | $0 | 0.00% | −29,881−100.0% | Sold out |
| Independent Financial Group, LLC | 0 | $0 | 0.00% | −29,637−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −26,250−100.0% | Sold out |
| Bryce Point Capital, LLC | 0 | $0 | 0.00% | −26,083−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −26,071−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −24,521−100.0% | Sold out |
| Congress Wealth Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −18,283−100.0% | Sold out |
| Steel Peak Wealth Management LLC | 0 | $0 | 0.00% | −16,106−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −15,600−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −14,008−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,108−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −12,974−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −11,591−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −5,242−100.0% | Sold out |
| Bayforest Capital Ltd | 0 | $0 | 0.00% | −2,496−100.0% | Sold out |
| Eastern Bank | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −1,630−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Asset Planning,Inc | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Richard W. Paul & Associates, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Hemington Wealth Management | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| AlphaMark Advisors, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Cassady Schiller Wealth Management, LLC | – | – | – | – | Not filed |